Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q2 2023 vs. Q1 2023
How the institutions holding Fortress Biotech, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 54 | 48 | −6 |
| Shares | 28.6M | 24.1M | −4.47M (−15.6%) |
| Value | $23.4M | $13.3M | −$10.1M (−43.3%) |
New holders (5)
Institutions that held Fortress Biotech, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 13,574 | $7.47K | 0.00% |
| Victory Capital Management Inc | 10,149 | $5.58K | 0.00% |
| Delta Asset Management LLC | 6,000 | $3.30K | 0.00% |
| Barclays PLC | 247 | $136 | 0.00% |
| Royal Bank of Canada | 472 | $0 | 0.00% |
Sold out (11)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Jefferies Financial Group Inc. | 2,850,000 | $2.34M |
| Millennium Management LLC | 115,349 | $95.0K |
| Two Sigma Securities, LLC | 36,189 | $29.7K |
| Two Sigma Advisers, LP | 25,900 | $21.2K |
| LPL Financial LLC | 20,000 | $16.4K |
| Virtu Financial LLC | 13,221 | $11.0K |
| Spotlight Asset Group, Inc. | 10,700 | $7.00K |
| Essex Investment Management Co LLC | 5,700 | $4.67K |
| First Manhattan Co | 2,549 | $2.09K |
| West Financial Advisors, LLC | 1,000 | $820 |
| Oliver Lagore Vanvalin Investment Group | 400 | $328 |